Nippon Kayaku Co., Ltd. Deal History & Licensing Activity
Nippon Kayaku Co., Ltd. is a life sciences. Over the past three years, Nippon Kayaku Co., Ltd. has been involved in 1 licensing and acquisition transaction, with a primary focus on ADC (2 deals).
Deals (12mo)
1
Active Trials
0
Top Modality
ADC
Focus Area
Oncology
Nippon Kayaku Co., Ltd. Recent Deal Activity
Licensing, acquisition, and partnership transactions involving Nippon Kayaku Co., Ltd. in the past 12 months.
| Asset | Partner | Modality | Phase | Type | Date |
|---|---|---|---|---|---|
| GNX201-ADC | GlycoNex Inc. | ADC | Preclinical | collaboration | Mar 2026 |
Nippon Kayaku Co., Ltd. Pipeline Focus
Therapeutic areas and modalities where Nippon Kayaku Co., Ltd. is most active based on deal history and clinical trial data.
See How Your Asset Matches Nippon Kayaku Co., Ltd.'s Portfolio
Use our deal calculator to benchmark upfront payments, milestones, and royalties for Oncology assets — powered by data from 3,500+ real biopharma transactions.
Related Intelligence
Oncology Deal Benchmarks
Market sizing, deal terms, and competitive landscape for oncology
ADC Benchmarks
Upfront, milestone, and royalty benchmarks for adc deals
Deal Pulse
Track the latest biopharma licensing and acquisition deals across all therapeutic areas
All Company Profiles
Browse 850+ biotech and pharma company profiles with deal history and pipeline data
2026 Deal Benchmarks Report
Industry-wide analysis of deal terms, trends, and market dynamics
About Nippon Kayaku Co., Ltd. Licensing & Deal Activity
Nippon Kayaku Co., Ltd. is a life sciences company that has been actively engaged in licensing transactions across the biopharma landscape. With 1 deal over the past three years, Nippon Kayaku Co., Ltd. ranks among the actively acquisitive companies tracked by Ambrosia Ventures.
Key therapeutic areas of focus for Nippon Kayaku Co., Ltd. include Oncology (2 deals and trials). In terms of modality, Nippon Kayaku Co., Ltd. has shown particular interest in adc.
Ambrosia Ventures tracks deal terms, pipeline data, patent expirations, and competitive positioning for Nippon Kayaku Co., Ltd. and 850+ other biopharma companies. Use our deal calculator to benchmark your asset against Nippon Kayaku Co., Ltd.'s historical deal terms, or explore all company profiles to find the best partner match for your pipeline.